FindTrial
Sign In

The value of liver and spleen stiffness in the survival prediction of patients with portal hypertension

The value of liver and spleen stiffness in the survival prediction of patients with portal hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029137
Enrollment
Unknown
Registered
2020-01-15
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal hypertension

Interventions

Case series:Nil

Sponsors

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of hepatoportal hypertension with esophageal and gastric varices or ascites; 2. Aged 18-75 years old; 3. Provision of informed consent before participating in the study.

Exclusion criteria

Exclusion criteria: 1. Combined with liver cancer or extrahepatic tumor; 2. Severe heart, lung, liver, kidney dysfunction, or severe bleeding disorders or local/systemic infections, hypothyroidism, Raynaud's syndrome, peripheral vascular disease, etc.; 3. Splenectomy patients; 4. Severe portal vein thrombosis; 5. Women who are planning to become pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
stiffness of liver and spleen;The relationship between the stiffness of liver and spleen and survival;—

Secondary

MeasureTime frame
Complications associated with portal hypertension;Changes of liver function;—

Countries

China

Contacts

Public ContactYuZheng Zhuge

Department of Gastroenterology, Drum Tower Hospital Affiliated to Nanjing University Medical College

yuzheng9111963@aliyun.com+86 15996289206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026